Association of HLA class I alleles with keloids in Chinese Han individuals

Human Immunology

Volumn 71, Issue 4, 2010, Pages 418-422

  Lu, Wen Sheng ^a,b   Cai, Li Qiong ^a,b,c   Wang, Zai Xing ^a,b   Li, Yang ^a,b   Wang, Jian Feng ^a,b   Xiao, Feng Li ^a,b   Quan, Cheng ^a,b   He, Su Min ^a,b   Yang, Sen ^a,b   Zhang, Xue Jun ^a,b  

^a Medical University   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Haplotype; HLA; Keloids; Polymerase chain reaction; Sequence specific primers

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; ETHNICITY; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; KELOID; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; KELOID; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 77950529399     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.11.004     Document Type: Article

References (27)

1. Olaitan P.B. Keloids: Assessment of effects and psychosocial-impacts on subjects in a black African population. Indian J Dermatol Venereol Leprol 2009, 75:368-372.
2. Brown B.C., McKenna S.P., Siddhi K., McGrouther D.A., Bayat A. The hidden cost of skin scars: Quality of life after skin scarring. J Plast Reconstr Aesthet Surg 2008, 61:1049-1058.
3. Seifert O., Mrowietz U. Keloid scarring: Bench and bedside. Arch Dermatol Rev 2009, 301:259-272.
4. Brown J.J., Bayat A. Genetic susceptibility to raised dermal scarring. Br J Dermatol 2009, 161:8-18.
5. Bayat A., Arscott G., Ollier W.E., McGrouther D.A., Ferguson M.W. Keloid disease: Clinical relevance of single versus multiple site scars. Br J Plast Surg 2005, 58:28-37.
6. Marneros A.G., Krieg T. Keloids-clinical diagnosis, pathogenesis, and treatment options. J Dtsch Dermatol Ges 2004, 2:905-913.
7. Marneros A.G., Norris J.E., Olsen B.R., Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001, 137:1429-1434.
8. Ramakrishnan K.M., Thomas K.P., Sundararajan C.R. Study of 1,000 patients with keloids in South India. Plast Reconstr Surg 1974, 53:276-280.
9. Brown J.J., Ollier W., Arscott G., Ke X., Lamb J., Day P., et al. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 2008, 17:610-613.
10. Chin D., Boyle G.M., Theile D.R., Parsons P.G., Coman W.B. The human genome and gene expression profiling. J Plast Reconstr Aesthet Surg 2006, 59:902-911.
11. Santucci M., Borgognoni L., Reali U.M., Gabbiani G. Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch 2001, 438:457-463.
12. Chen D., Wang Q., Bao W., Xu S., Tang Y. Role of HLA-DR and CD1a molecules in pathogenesis of hypertrophic scarring and keloids. Chin Med J (Engl) 2003, 116:314-315.
13. Lu W.S., Wang J.F., Yang S., Xiao F.L., Quan C., Cheng H., et al. Association of HLA-DQA1 and DQB1 alleles with keloids in Chinese Hans. J Dermatol Sci 2008, 52:108-117.
14. Brown J.J., Ollier W.E., Thomson W., Bayat A. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 2008, 35:303-307.
15. Joung C.I., Jun J.B., Chung W.T., Song G.G., Choe J.Y., Chang H.K., et al. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea. Scand J Rheumatol 2006, 35:39-43.
16. Idriss N., Maibach H.I. Scar assessment scales: A dermatologic overview. Skin Res Technol 2009, 15:1-5.
17. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
18. Olerup O., Aldener A., Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993, 41:119-134.
19. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235.
20. Murdaca G., Contini P., Setti M., Cagnati P., Villa R., Lantieri F., et al. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: Correlation with clinical outcome. Hum Immunol 2007, 68:894-900.
21. Borrego F., Kabat J., Kim D.K., Lieto L., Maasho K., Pena J., et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002, 38:637-660.
22. Winter C.C., Gumperz J.E., Parham P., Long E.O., Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998, 161:571-577.
23. Colonna M., Borsellino G., Falco M., Ferrara G.B., Strominger J.L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A 1993, 90:12000-12004.
24. Mandelboim O., Reyburn H.T., Vales-Gomez M., Pazmany L., Colonna M., Borsellino G., et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996, 184:913-922.
25. Castagnoli C., Trombotto C., Ondei S., Stella M., Calcagni M., Magliacani G., et al. Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns 1997, 23:565-572.
26. Laurentaci G., Dioguardi D. HLA antigens in keloids and hypertrophic scars. Arch Dermatol 1977, 113:1726.
27. Rossi A., Bozzi M. HLA and keloids: Antigenic frequency and therapeutic response. G Ital Dermatol Venereol 1989, 124:341-344.